While STT3A, the catalytic OST subunit, has been well characterized as both the enzymatic core and a druggable target, the STT3A dependence of the role of DDOST in HCC pathogenesis remains unresolved. This evidence concerns the gene STT3A and hepatocellular carcinoma.